2502
CONCLUSION: A woman receiving enoxaparin every 12 hours developed signs and symptoms of hepatotoxicity after the second dose.
 ( adverse event: developed ,  A woman: Subject, woman: Subject.Gender, signs and symptoms of hepatotoxicity: Effect, enoxaparin every 12 hours: Treatment, after the second dose: Treatment, enoxaparin: Treatment.Drug, every 12 hours: Treatment.Freq, the second dose.: Treatment.Dosage) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  A woman: Subject, woman: Subject.Gender, signs and symptoms of hepatotoxicity: Effect, enoxaparin every 12 hours: Treatment, after the second dose: Treatment, enoxaparin: Treatment.Drug, every 12 hours: Treatment.Freq, the second dose.: Treatment.Dosage) 